Improved survival in homozygous sickle cell disease: lessons from a cohort study
- PMID: 8555802
- PMCID: PMC2551498
- DOI: 10.1136/bmj.311.7020.1600
Improved survival in homozygous sickle cell disease: lessons from a cohort study
Abstract
Objective: To examine whether simple interventions in a sickle cell clinic improve survival in sickle cell disease.
Design: Survival curve analysis and hazard ratios in a cohort study followed from birth.
Setting: MRC Laboratories (Jamaica) at the University of the West Indies, and Victoria Jubilee Hospital, Kingston, Jamaica.
Subjects: 315 patients with homozygous sickle cell disease detected during the screening of 100,000 consecutive non-operative deliveries between June 1973 and December 1981 at the main government maternity hospital, Kingston, Jamaica.
Interventions: Prophylactic penicillin to prevent pneumococcal septicaemia, parental education in early diagnosis of acute splenic sequestration, close monitoring in sickle cell clinic.
Main outcome measures: Survival.
Results: Survival appeared to improve, the log rank test for trend comparing the first, second, and last third of the study reaching borderline significance (P = 0.05). Combined deaths from acute splenic sequestration and pneumococcal septicaemia-meningitis declined significantly (test for trend, P = 0.02).
Conclusion: Early diagnosis and simple prophylactic measures significantly reduce deaths associated with homozygous sickle cell disease.
Similar articles
-
Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth.PLoS One. 2018 Mar 1;13(3):e0192710. doi: 10.1371/journal.pone.0192710. eCollection 2018. PLoS One. 2018. PMID: 29494636 Free PMC article.
-
Management of sickle cell disease; lessons from the Jamaican Cohort Study.Blood Rev. 1993 Sep;7(3):137-45. doi: 10.1016/0268-960x(93)90001-k. Blood Rev. 1993. PMID: 8241829 Review.
-
Treatment of sickle cell disease in early childhood in Jamaica.Am J Pediatr Hematol Oncol. 1985 Fall;7(3):235-9. doi: 10.1097/00043426-198507030-00005. Am J Pediatr Hematol Oncol. 1985. PMID: 3907390 Clinical Trial.
-
Causes of death in sickle-cell disease in Jamaica.Br Med J (Clin Res Ed). 1982 Aug 28-Sep 4;285(6342):633-5. doi: 10.1136/bmj.285.6342.633. Br Med J (Clin Res Ed). 1982. PMID: 6819042 Free PMC article.
-
Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance.Am Fam Physician. 2000 Sep 1;62(5):1013-20, 1027-8. Am Fam Physician. 2000. PMID: 10997528 Review.
Cited by
-
Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease.PLoS One. 2016 Oct 20;11(10):e0164743. doi: 10.1371/journal.pone.0164743. eCollection 2016. PLoS One. 2016. PMID: 27764159 Free PMC article.
-
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.Lancet Haematol. 2023 Aug;10(8):e633-e686. doi: 10.1016/S2352-3026(23)00096-0. Epub 2023 Jul 11. Lancet Haematol. 2023. PMID: 37451304 Free PMC article. Review.
-
Association of care in a medical home and health care utilization among children with sickle cell disease.J Natl Med Assoc. 2013 Summer;105(2):157-65. doi: 10.1016/s0027-9684(15)30109-7. J Natl Med Assoc. 2013. PMID: 24079216 Free PMC article.
-
Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia.Front Med (Lausanne). 2021 Nov 10;8:734305. doi: 10.3389/fmed.2021.734305. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34859003 Free PMC article.
-
Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.Eur J Hum Genet. 2014 Aug;22(8):1051-3. doi: 10.1038/ejhg.2013.286. Epub 2014 Jan 8. Eur J Hum Genet. 2014. PMID: 24398797 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical